An Observational Study to Assess the Quality of Life of the Patients With Multiple Sclerosis and Their Caregivers
NCT ID: NCT01075737
Last Updated: 2014-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
141 participants
OBSERVATIONAL
2008-08-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Observational, Prospective Study to Assess the Impact of Fatigue in the Quality of Life of Patients With Multiple Sclerosis in Argentina
NCT01080001
Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)
NCT01080053
Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina
NCT01080014
A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment
NCT00702065
Disability, Perceived Social Support and Quality of Life in Multiple Sclerosis
NCT02880553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
OBJECTIVES
Primary objective:
* To identify the impact of MS on the QoL of the MS subjects and their caregivers
Secondary objectives:
* To establish the correlation between the QoL of the subjects with MS and their caregivers
* To identify the predictors of the QoL in the caregiver group
This is an observational, prospective and non-interventional study planned to be conducted in 20 centers in Argentina. The subjects with diagnosed MS will be managed with the clinical and therapeutic elements that their treating doctors considered appropriate, without modifying their decisions due to the subjects' inclusion into the study. The caregivers will be asked to complete the QoL questionnaire as a part of the normal interview on each and every visit. The total duration of the study is 24 months. A descriptive analysis will be performed for the demographic and clinical characteristics of the investigation subjects, as well as for the characteristics of the treatments they receive when they start their participation in this study. For the qualitative variables, treatment modifications, frequency tables and the percentages will be performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with Multiple Sclerosis
Subjects with diagnosed MS according to the revised Mc Donald criteria 2005; aged \>21 years.
No interventions assigned to this group
Caregivers
Caregivers (aged \>21 years) for MS subjects.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who have signed informed consent
* Subjects with established MS diagnosis according to the revised Mc Donald criteria - 2005 with at least 1 year of evolution
* Subjects with MS that have an identified caregiver
Exclusion Criteria
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck KGaA, Darmstadt, Germany
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miguel Jacobo, Neurologist
Role: PRINCIPAL_INVESTIGATOR
25 de Mayo 138 (Capital, Pcia. de Santiago del Estero) G4200AWD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
25 de Mayo 138, Capital, Pcia. de
Santiago del Estero, , Argentina
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200077-501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.